http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2181996-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
filingDate 1997-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2003-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afc7bdfcd709c42422cb6b88b05849d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8bec2c4481064cb1d64d6f4c4abb96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5df281d89fd3653b77c632bd4ef35fa5
publicationDate 2003-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2181996-T3
titleOfInvention BENZOTIOPHENE COMPOUNDS AND PROCEDURES IN USE.
abstract THIS INVENTION PROVIDES NEW FORMULA BENZOTIOPHENE COMPOUNDS I: IN WHICH: R {SUB, 1} IS O (RENT C {SUB, 1} {SUB, 6}), CO STITUTED, OB, 2} ES (RENT C {SUB, 1} NONLY REPLACED, OPTIONALLY REPLACED NILE, OR, 4} CH {SUB, 2} NR {SUB, 3} R {SUB, 4}; R {SUB, 3} YR {SUB, 4} ARE EACH ONE INDEPENDENTLY RENT C {SUB, 1} TO FORM, WITH THE NITROGEN TO WHICH THEY ARE UNITED, PIPERIDINYL, PIRROLIDINYL, METHYL-PIRROLIDINYL, DIMETHYL PIRROLIDINYL OR HEXAMETILENIMINE; , IN PARTICULAR OSTEOPOROSIS, PATHOLOGICAL STATES RELATED TO THE CARDIOVASCULAR SYSTEM INCLUDING HYPERLIPIDEMIES AND RELATED CARDIOVASCULAR PATHOLOGIES, AND CANCER DEPENDENT ON STROGEN.
priorityDate 1996-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419694116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559535

Total number of triples: 38.